Schedule 13D ownership disclosure

AMBRX BIOPHARMA INC

Security class unavailable · CUSIP: 02290A102

Event date: 2023-03-06

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
79,132,011
Percent of class
26.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-23-002154
Form type
SC 13D
Filer
Ambrx Biopharma Cayman, Inc.
CIK
CIK 1836056
Filed
Mar 08, 2023
Reporting period
Mar 06, 2023
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub